Cardio Diagnostics Holdings, Inc. (CDIO) vs Ensysce Biosciences, Inc. (ENSC)
A side-by-side comparison of Cardio Diagnostics Holdings, Inc. and Ensysce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDIO
Cardio Diagnostics Holdings, Inc.
$2.06HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENSC
Ensysce Biosciences, Inc.
$0.42HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CDIO vs ENSC
growth of $100 · dividends reinvested · last 5yCDIO -99.3% (-62.9%/yr)ENSC -100.0% (-87.1%/yr)CDIO compounded faster over this window
Log scale — wide-divergence pair
CDIO ENSC
CDIO vs ENSC: by the numbers
- •ENSC is the larger company ($6M vs $6M market cap).
- •Both run net losses; ENSC's is the smaller (-1084.23% vs -44771.83% net margin).
Metrics side by side
Valuation
| Metric | CDIO | ENSC |
|---|---|---|
| P/S ratio | 421.90 | 5.53 |
| P/B ratio | 0.82 | N/A |
Profitability
| Metric | CDIO | ENSC |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -43737.46% | 0.00% |
| Net margin | -44771.83% | -1084.23% |
| ROE | -87.12% | N/A |
| ROIC | -82.84% | N/A |
Growth (annualized)
| Metric | CDIO | ENSC |
|---|---|---|
| Total return CAGR (5Y) | N/A | -86.22% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.